Global Live-type Poultry Vaccine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Live-type Poultry Vaccine Market Research Report 2024
A live-type poultry vaccine contains a virus or bacteria that must infect the chicken and multiply in its body to produce immunity, preferably with minimal reaction. Multiplication of the virus in the chicken is necessary, as only relatively small amounts of virus are administered to the bird.
According to Mr Accuracy reports’s new survey, global Live-type Poultry Vaccine market is projected to reach US$ 1197.4 million in 2034, increasing from US$ 895.5 million in 2024, with the CAGR of 4.3% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Live-type Poultry Vaccine market research.
Key manufacturers engaged in the Live-type Poultry Vaccine industry include MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Live-type Poultry Vaccine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Live-type Poultry Vaccine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Live-type Poultry Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Segment by Type
Newcastle Disease Vaccine
Infectious Bronchitis Vaccine
Fowl Pox Vaccine
Marek’s Disease Vaccine
Fowl Typhoid Vaccine
Live Coccidiosis Vaccine
Other
Chicken
Other Poultry
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Live-type Poultry Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Live-type Poultry Vaccine market is projected to reach US$ 1197.4 million in 2034, increasing from US$ 895.5 million in 2024, with the CAGR of 4.3% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Live-type Poultry Vaccine market research.
Key manufacturers engaged in the Live-type Poultry Vaccine industry include MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, ZOETIS, Vaxxinova, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Live-type Poultry Vaccine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Live-type Poultry Vaccine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Live-type Poultry Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Segment by Type
Newcastle Disease Vaccine
Infectious Bronchitis Vaccine
Fowl Pox Vaccine
Marek’s Disease Vaccine
Fowl Typhoid Vaccine
Live Coccidiosis Vaccine
Other
Segment by Application
Chicken
Other Poultry
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Live-type Poultry Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices